Advertisement

Document › Details
Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London.
Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce the appointment of Tracy Cheung as a Partner, effective 23 May 2022.
Tracy has more than 25 years of communications and leadership experience, working with diverse stakeholders and senior executives in healthcare across a range of disciplines including corporate and financial communications, media relations, investor relations, issues and crisis management, employee and change engagement, public affairs and marketing communications.
Tracy joins Consilium from COMPASS Pathways, a Nasdaq-listed mental health care company. As COMPASS’s Chief Communications Officer, she led communications through a number of financing rounds (including the Nasdaq IPO) and clinical data milestones and helped to establish the company as a leader in psychedelic medicine and mental health care. Tracy has held leadership roles in several other healthcare and life sciences organisations, including Amersham plc, GE Healthcare Medical Diagnostics and Essentia (part of Guy’s and St Thomas’ NHS Foundation Trust). She has worked in the UK and the US, and as an advisor in an independent capacity as well as for advisory firms Brunswick Group and Rowland Sallingbury Casey.
“Tracy brings deep international healthcare experience to Consilium and further expands our strength and capabilities at a senior level, particularly from a US angle. Her appointment reflects our continued growth, ambition, and our commitment to providing the highest quality advice and service to our healthcare clients globally. I look forward to welcoming her to the team as a new Partner soon.”
MARY-JANE ELLIOTT
Managing Partner of Consilium Strategic Communications
"I am hugely excited to be joining Consilium, a global leader in strategic healthcare communications and investor relations. Having worked with them as a client, I know that their dedicated focus to healthcare gives them a deep insight into and passion for the sector. I look forward to working with the team to add value to clients as they deliver innovation in healthcare for the benefit of patients, healthcare professionals and investors.
TRACY CHEUNG
Tracy Cheung, newly appointed Partner of Consilium Strategic Communications
Tracy Cheung can be contacted at [email protected]
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
[email protected]
www.consilium-comms.com
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in both Europe and US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
For more information, please see www.consilium-comms.com
Record changed: 2024-12-22 |
Advertisement

More documents for ICR (Group)
- [1] Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss....
- [2] ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London....
- [3] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [4] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [5] Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel....
- [6] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [7] Glycotope GmbH. (3/24/22). "Press Release: Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform". Berlin....
- [8] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [9] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
- [10] Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top